Literature DB >> 28496053

Chemical and structural biology of protein lysine deacetylases.

Minoru Yoshida1, Norio Kudo1, Saori Kosono1,2, Akihiro Ito1.   

Abstract

Histone acetylation is a reversible posttranslational modification that plays a fundamental role in regulating eukaryotic gene expression and chromatin structure/function. Key enzymes for removing acetyl groups from n class="Chemical">histones are metal (zinc)-dependent and NAD+-dependent histone deacetylases (HDACs). The molecular function of HDACs have been extensively characterized by various approaches including chemical, molecular, and structural biology, which demonstrated that HDACs regulate cell proliferation, differentiation, and metabolic homeostasis, and that their alterations are deeply involved in various human disorders including cancer. Notably, drug discovery efforts have achieved success in developing HDAC-targeting therapeutics for treatment of several cancers. However, recent advancements in proteomics technology have revealed much broader aspects of HDACs beyond gene expression control. Not only histones but also a large number of cellular proteins are subject to acetylation by histone acetyltransferases (HATs) and deacetylation by HDACs. Furthermore, some of their structures can flexibly accept and hydrolyze other acyl groups on protein lysine residues. This review mainly focuses on structural aspects of HDAC enzymatic activity regulated by interaction with substrates, co-factors, small molecule inhibitors, and activators.

Entities:  

Keywords:  acetylation; acylation; cancer; chromatin; epigenetics; sirtuin

Mesh:

Substances:

Year:  2017        PMID: 28496053      PMCID: PMC5489435          DOI: 10.2183/pjab.93.019

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  183 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

3.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

4.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Authors:  V M Richon; S Emiliani; E Verdin; Y Webb; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.

Authors:  S J Darkin-Rattray; A M Gurnett; R W Myers; P M Dulski; T M Crumley; J J Allocco; C Cannova; P T Meinke; S L Colletti; M A Bednarek; S B Singh; M A Goetz; A W Dombrowski; J D Polishook; D M Schmatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

7.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

8.  HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine.

Authors:  Pornpun Aramsangtienchai; Nicole A Spiegelman; Bin He; Seth P Miller; Lunzhi Dai; Yingming Zhao; Hening Lin
Journal:  ACS Chem Biol       Date:  2016-08-05       Impact factor: 5.100

Review 9.  Cortactin branches out: roles in regulating protrusive actin dynamics.

Authors:  Amanda Gatesman Ammer; Scott A Weed
Journal:  Cell Motil Cytoskeleton       Date:  2008-09

10.  A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol.

Authors:  Mathew Sajish; Paul Schimmel
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

View more
  22 in total

1.  Live-Cell Imaging of Sirtuin Activity Using a One-Step Fluorescence Probe.

Authors:  Mitsuyasu Kawaguchi; Hidehiko Nakagawa
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Epigenetic drug discovery: a success story for cofactor interference.

Authors:  A Ganesan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

3.  Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.

Authors:  Norio Kudo; Akihiro Ito; Mayumi Arata; Akiko Nakata; Minoru Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

4.  HDAC inhibitors rescue multiple disease-causing CFTR variants.

Authors:  Frédéric Anglès; Darren M Hutt; William E Balch
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

Review 5.  Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends.

Authors:  Kunal Nepali; Jing-Ping Liou
Journal:  J Biomed Sci       Date:  2021-04-12       Impact factor: 8.410

Review 6.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

7.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

8.  Structure of Arabidopsis HISTONE DEACETYLASE15.

Authors:  Chia-Yang Chen; Yi-Tsung Tu; Jhe-Cheng Hsu; Heng-Chen Hung; Ting-Chun Liu; Yu-Hsuan Lee; Chun-Chi Chou; Yi-Sheng Cheng; Keqiang Wu
Journal:  Plant Physiol       Date:  2020-09-02       Impact factor: 8.340

9.  Chelatable trace zinc causes low, irreproducible KDAC8 activity.

Authors:  Tasha B Toro; Samantha A Edenfield; Brandon J Hylton; Terry J Watt
Journal:  Anal Biochem       Date:  2017-10-31       Impact factor: 3.365

Review 10.  Epigenetics of addiction.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi
Journal:  Neurochem Int       Date:  2021-05-13       Impact factor: 4.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.